Archives
Merck strikes €20m deal with Ablynx for new generation cancer drugs
Ablynx, a Belgian biotechnology firm, has agreed to a €20 million deal with Merck to develop immunotherapies that can bolster the human body's potential to combat cancer cells, the Financial Times reported.
Xanadu to acquire copper-gold project in Mongolia for $14M
Exploration company Xanadu Mines, together with its joint venture firm Mongol Metals, have agreed to purchase a 90% stake in the Kharmagtai copper-gold project in Mongolia from Turquoise Hill Resources in a $14-million deal.
FTC's regulatory overreach of the year so far: Redesigning the iPad
It may still be the first two months of the 2014 but redesigning Apple's iPad is probably the regulatory overreach of the year committed by the Federal Trade Commission, The Wall Street Journal reported.
Cfius set to scrutinize Lenovo's purchase of Motorola's handset business
The Committee on Foreign Investment in the United States or Cfius is expected to thoroughly scrutinize the $2.9 billion acquisition of Motorola's handset business by Chinese technology firm Lenovo.